back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2016-02-22 Tx date 2016-02-18 |
$VRX
Valeant Pharmaceuticals International, Inc. |
Schiller, Howard
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$558,027
+6,102 vol $91.45 each |
289,369 | |
| Filed 2016-02-22 Tx date 2016-02-18 |
$VRX
Valeant Pharmaceuticals International, Inc. |
Schiller, Howard
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
$-558,027.90
-6,102 vol $91.45 each |
1,506 | |
| Filed 2016-02-22 Tx date 2016-02-18 |
$VRX
Valeant Pharmaceuticals International, Inc. |
Schiller, Howard
4 - Director of Issuer
Direct Ownership
|
Performance Share Units
57 - Exercise of rights
|
$-9,145,000
-100,000 vol $91.45 each |
0 | |
| Filed 2016-02-22 Tx date 2016-02-18 |
$VRX
Valeant Pharmaceuticals International, Inc. |
Schiller, Howard
4 - Director of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-4,741,316.70
-51,846 vol $91.45 each |
335,278 | |
| Filed 2016-02-22 Tx date 2016-02-18 |
$VRX
Valeant Pharmaceuticals International, Inc. |
Schiller, Howard
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$9,145,000
+100,000 vol $91.45 each |
387,124 | |
| Filed 2016-02-22 Tx date 2016-02-18 |
$VRX
Valeant Pharmaceuticals International, Inc. |
Schiller, Howard
4 - Director of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-205,305.25
-2,245 vol $91.45 each |
287,124 | |
| Filed 2016-01-04 Tx date 2015-07-01 |
$VRX
Valeant Pharmaceuticals International, Inc. |
Schiller, Howard
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
$343,729
+1,506 vol $228.24 each |
7,608 | |
| Filed 2015-04-28 Tx date 2015-04-27 |
$VRX
Valeant Pharmaceuticals International, Inc. |
Schiller, Howard
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
-4,859 vol |
283,267 | |
| Filed 2015-04-28 Tx date 2015-04-27 |
$VRX
Valeant Pharmaceuticals International, Inc. |
Schiller, Howard
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
$-1,872,321.36
-9,268 vol $202.02 each |
6,102 | |
| Filed 2015-04-28 Tx date 2015-04-27 |
$VRX
Valeant Pharmaceuticals International, Inc. |
Schiller, Howard
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
57 - Exercise of rights
|
$-4,545,450
-22,500 vol $202.02 each |
100,000 | |
| Filed 2015-04-28 Tx date 2015-04-27 |
$VRX
Valeant Pharmaceuticals International, Inc. |
Schiller, Howard
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$1,872,321
+9,268 vol $202.02 each |
288,126 | |
| Filed 2015-04-28 Tx date 2015-04-27 |
$VRX
Valeant Pharmaceuticals International, Inc. |
Schiller, Howard
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-2,379,593.58
-11,779 vol $202.02 each |
278,858 | |
| Filed 2015-04-28 Tx date 2015-04-27 |
$VRX
Valeant Pharmaceuticals International, Inc. |
Schiller, Howard
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$4,545,450
+22,500 vol $202.02 each |
290,637 |